We are live on ! Find out more
RC

Rangeley Capital Portfolio holdings

AUM $103M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
-9.22%
1 Year Est. Return
+77.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$93.4M
AUM Growth
-$18M
Cap. Flow
-$1.42M
Cap. Flow %
-1.52%
Top 10 Hldgs %
47.34%
Holding
111
New
29
Increased
12
Reduced
26
Closed
34

Sector Composition

Rank Sector Weight
1 Healthcare 28.65%
2 Energy 16.07%
3 Consumer Discretionary 9.66%
4 Real Estate 9.29%
5 Materials 9.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BFIN
26
DELISTED
BankFinancial
BFIN
$1.12M 1.2%
89,000
STHO icon
27
Star Holdings Shares of Beneficial Interest
STHO
$112M
$1.1M 1.18%
129,000
+2,000
+2% +$17.4K
THRD
28
DELISTED
Third Harmonic Bio
THRD
$937K 1%
+270,000
New +$1.31M
DRDB
29
Roman DBDR Acquisition Corp II
DRDB
$325M
$894K 0.96%
+89,167
New +$888K
MLACR
30
DELISTED
Mountain Lake Acquisition Corp Right
MLACR
$804K 0.86%
+80,000
New +$15.4K
SWKH
31
DELISTED
SWK Holdings
SWKH
$759K 0.81%
55,101
FNA
32
DELISTED
Paragon 28, Inc.
FNA
$653K 0.7%
+50,000
New +$622K
TRIP icon
33
TripAdvisor
TRIP
$1.66B
$638K 0.68%
+45,009
New +$705K
CORZ icon
34
Core Scientific
CORZ
$6.59B
$626K 0.67%
86,400
-86,400
-50% -$983K
HYG icon
35
PUT
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$592K 0.63%
+7,500
New +$595K
SWTX
36
CALL
DELISTED
SpringWorks Therapeutics
SWTX
$583K 0.62%
+13,200
New +$608K
DESP
37
DELISTED
Despegar.com
DESP
$558K 0.6%
+29,702
New +$570K
SMC
38
Summit Midstream
SMC
$412M
$508K 0.54%
15,000
-42,777
-74% -$1.72M
BBIO icon
39
BridgeBio Pharma
BBIO
$16.5B
$449K 0.48%
13,000
DRDBW
40
Roman DBDR Acquisition Corp II Warrants
DRDBW
$447K 0.48%
+44,583
New +$13.4K
TUSK icon
41
Mammoth Energy Services
TUSK
$131M
$420K 0.45%
205,880
-226,458
-52% -$604K
HEPS
42
D-Market Electronic Services & Trading
HEPS
$1.01B
$411K 0.44%
144,326
+44,326
+44% +$144K
HHH icon
43
Howard Hughes
HHH
$3.93B
$354K 0.38%
4,781
-6,182
-56% -$467K
CRGX
44
DELISTED
CARGO Therapeutics
CRGX
$333K 0.36%
+81,851
New +$548K
SEPN
45
Septerna Inc
SEPN
$1.51B
$307K 0.33%
+52,950
New +$605K
MLAC
46
DELISTED
Mountain Lake Acquisition Corp
MLAC
$291K 0.31%
+29,000
New +$290K
CEP
47
DELISTED
Cantor Equity Partners
CEP
$284K 0.3%
26,482
INBX icon
48
Inhibrx
INBX
$1.21B
$249K 0.27%
17,810
-31,591
-64% -$429K
BATRK icon
49
Atlanta Braves Holdings Series B
BATRK
$3.25B
$239K 0.26%
5,981
-4,019
-40% -$157K
CDLX icon
50
Cardlytics
CDLX
$21.7M
$237K 0.25%
13,000
-19,000
-59% -$543K

Similar funds

Rangeley Capital's Q1 2025 Portfolio in Review

As of Q1 2025, Rangeley Capital held 111 positions worth $93.4M, down 16% from $111M the previous quarter. Its ten largest holdings account for 47% of the portfolio.

Rangeley Capital's Q1 2025 filing shows 29 new, 12 increased, 26 reduced and 34 closed positions. Its largest new stake was Arvinas: 543,000 shares worth $3.81M. The largest sale was Roman DBDR Acquisition Corp II Unit, an estimated $2.17M.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, up from 13% a quarter earlier, followed by Energy and Consumer Discretionary.

  • Rangeley Capital's largest Q1 2025 buy was Arvinas: 543,000 shares worth $3.81M.
  • Rangeley Capital added most to Jack in the Box in Q1 2025, an estimated $607K increase.
  • Rangeley Capital's biggest Q1 2025 reduction was Net Lease Office Properties, cutting an estimated $1.8M.
  • Rangeley Capital fully exited Roman DBDR Acquisition Corp II Unit in Q1 2025, selling an estimated $2.17M.
  • Rangeley Capital's ten largest holdings make up 47% of its $93.4M portfolio in Q1 2025.
  • Rangeley Capital opened 29 new positions and closed 34 in Q1 2025.
  • Rangeley Capital's portfolio value fell 16% quarter-over-quarter to $93.4M.

Based on Rangeley Capital's 13F filing for Q1 2025, filed 14 May 2025.